9 results on '"Tapscott S"'
Search Results
2. FSHD / OPMD / MYOTONIC DYSTROPHY: P.231 A biomarker of DUX4 activity to evaluate losmapimod treatment effect in FSHD Phase 2 trials
3. FSHD / OPMD / MYOTONIC DYSTROPHY: P.233 Longitudinal changes in MRI and functional outcome measures in facioscapulohumeral dystrophy
4. FSHD / OPMD / MYOTONIC DYSTROPHY: P.225 CRISPR-Cas9 mediated removal of an intronic SMCHD1 mutation supresses DUX4 expression in FSHD myocytes in vitro
5. P.47Design of a biomarker of DUX4 activity to evaluate losmapimod treatment effect in FSHD Phase 2 trials
6. NEW GENES, FUNCTIONS AND BIOMARKERS: O.4Single-cell RNA-sequencing in facioscapulohumeral muscular dystrophy disease: etiology and development
7. P.350 - Smchd1 haploinsufficiency exacerbates the phenotype of a transgenic FSHD1 mouse model
8. P.265 - Monosomy 18p: Risks for developing FSHD
9. A.O.8 - Gene variants in SMCHD1 and DNMT3B modify the risk for FSHD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.